NM_006231.4:c.2209A>G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_006231.4(POLE):c.2209A>G(p.Thr737Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_006231.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251486Hom.: 0 AF XY: 0.0000368 AC XY: 5AN XY: 135920
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461784Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 727206
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74486
ClinVar
Submissions by phenotype
not provided Uncertain:2
Identified as a germline variant in a patient with breast cancer (Guindalini et al., 2022); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 35264596) -
This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 737 of the POLE protein (p.Thr737Ala). This variant is present in population databases (rs779102091, gnomAD 0.005%). This missense change has been observed in individual(s) with breast cancer and/or pancreatic cancer (PMID: 35264596, 36896836). ClinVar contains an entry for this variant (Variation ID: 405791). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on POLE protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
- -
Familial colorectal cancer Uncertain:1
- -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.T737A variant (also known as c.2209A>G), located in coding exon 20 of the POLE gene, results from an A to G substitution at nucleotide position 2209. The threonine at codon 737 is replaced by alanine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at